48,830
edits
Difference between revisions of "Micropapillary urothelial carcinoma"
Jump to navigation
Jump to search
Micropapillary urothelial carcinoma (view source)
Revision as of 09:19, 15 June 2015
, 09:19, 15 June 2015→IHC
(→IHC) |
|||
| Line 33: | Line 33: | ||
*EMA +ve.<ref name=pmid25673582/> | *EMA +ve.<ref name=pmid25673582/> | ||
*HER2 +ve/-ve.<ref name=pmid25673582/> | *HER2 +ve/-ve.<ref name=pmid25673582/> | ||
*p63 -ve/+ve.</ref name=pmid24993315>{{Cite journal | last1 = Lin | first1 = X. | last2 = Zhu | first2 = B. | last3 = Villa | first3 = C. | last4 = Zhong | first4 = M. | last5 = Kundu | first5 = S. | last6 = Rohan | first6 = SM. | last7 = Yang | first7 = XJ. | title = The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma. | journal = Hum Pathol | volume = 45 | issue = 9 | pages = 1824-9 | month = Sep | year = 2014 | doi = 10.1016/j.humpath.2014.04.015 | PMID = 24993315 }}</ref> | |||
*p40 -ve/+ve.</ref name=pmid24993315/> | |||
*GATA3 +ve.</ref name=pmid24993315/> | |||
==Sign out== | ==Sign out== | ||